Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$15,000.00
Mar 19, 2024
For-profit organization
Develop digital adoption plan
$366,946.00
Mar 14, 2024
Academia
AAV Gene Therapy for the Treatment of Lipoprotein Lipase Deficiency
1014773
The project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency.
$15,000.00
Mar 4, 2024
For-profit organization
Develop digital adoption plan
$691,045.00
Feb 20, 2024
Not-for-profit organization or charity
Development and application of qualified testing in support of Clinical CAR-T Products
1015631
In the Project, OHRI will build on their success in establishing clinical grade manufacturing for both lentivirus and cell products, and the execution of the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The project includes building capacity in point-of-care (POC) manufacturing to support the clinical rollout of novel CAR T-cell products and other personalized cell therapy products.
$14,175.00
Feb 20, 2024
For-profit organization
Develop digital adoption plan
$24,894.00
Feb 19, 2024
For-profit organization
Patent Filings for New Applications of Sona Gold Nanorods for Targeted Hyperthermia Therapy and Other Applications
1015813
Sona Nanotech Inc. has a patented and patent-pending technology for manufacturing biocompatible, toxin-free gold nanorods. The goal of the intellectual property work outlined in this proposal is to enable Sona to file additional patent(s) covering new capabilities of the nanorods. The deliverables of this project will be a patent landscape report that includes patent search details, patent publication level results, patent assignee analysis, subject matter analysis, country analysis, and date analysis. This report will then be used to formulate and refine a strategy for Sona's next patent filings, starting with provisional patent filings to establish a priority date for the inventions disclosed in the application.
$15,000.00
Feb 16, 2024
For-profit organization
Develop digital adoption plan
$15,000.00
Feb 16, 2024
For-profit organization
Develop digital adoption plan
$14,450.00
Feb 13, 2024
For-profit organization
Develop digital adoption plan
$450,000.00
Feb 1, 2024
For-profit organization
CIIP Korea - MTD-TPC - Music Therapy Devices for Mental Health: A Trans-Pacific Collaboration
1015298
LUCID, a Canadian digital health startup, and Emma Healthcare, a Korean SME specializing in advanced diagnostics, are collaborating to revolutionize neuropsychiatric care through the co-development of an AI-based music therapy solution. LUCID's BioMIR technology, which analyzes user data and predicts emotional and cognitive states to personalize digital music therapy, will be enhanced with Emma Healthcare's diagnostic capabilities and measurement expertise. This joint effort aims to optimize the effectiveness of the therapy offering by training it on diverse datasets from North American and Asian populations, ultimately providing personalized, clinically validated music therapy solutions for improved mental well-being worldwide.